Influenza Diagnostics Market Overview
Introduction
Influenza Diagnostics Market was valued at US$ 8.5 Billion in 2024 and is projected to grow at a CAGR of 10.40% to reach US$ 21 Billion by 2034.
Influenza Diagnostics is the infection of respiratory parts like nose, throat and lungs. Influenza is also called as ‘Flu’. There are four types of influenza virus like Influenza A, Influenza B, Influenza C, and Influenza D virus. In U.S. human influenza A & B virus causes seasonal flu in every winter season. Influenza A are only viruses that causes flu pandemics. Influenza causes inflammation of heart, multi organ failure like respiratory & kidney failure, inflammation of muscle tissues, etc. Many diagnostic tests are available for influenza testing. Diagnostic tests like serology, viral culture, rapid molecular assays, RT-PCR (reverse transcriptase polymerase chain reaction), and rapid antigen testing are different types of diagnostic test used to diagnose influenza virus. RT-PCR has become the gold standard for confirmation of influenza virus. Influenza is detected by blood test or by taking sample from respiratory tract. Influenza A virus is carried by animals and Influenza B virus is contracted by humans. Influenza A & Influenza B strains are transmitted by contact with an infected person and by respiratory droplets from coughing. Influenza A is the most common influenza virus. Influenza virus is caused by flu when tiny airborne droplets from cough or sneezing of infected person is breathed by healthy individual. Oseltamivir phosphate, Peramivir, Zanamivir, and Baloxavir marboxil are FDA approved antiviral drugs used for treating flu and are recommended by CDC (Centers for Disease Control and Prevention). Symptoms of Influenza vary by age, presence of underlying medication condition and immune status. Uncomplicated influenza includes symptoms like nasal congestion, dry cough, runny nose, headache, fever, lack of energy, muscle ache, etc. Number of tests are available in diagnosing Influenza virus. RIDTs (rapid influenza diagnostic tests) provides results within 15 minutes. Viral culture test provides result within 3 to 10 days. Rapid molecular assays produce results within 20 minutes with high sensitivity and specificity.
Influenza Diagnostics Market Dynamics
Rise in prevalence of influenza virus and rate of urbanization
Rise in prevalence of influenza virus and rate of urbanization is one of the leading factors for the Influenza Diagnostic Market growth. Urbanization has given rise in consumption of western food, unhealthy lifestyle, lack of exercise, rapid industrialization, more use of vehicles, rise in air pollution, climatic change like change in environmental humidity and other seasonal factors has given rise in influenza virus. According to weekly data obtained from 603 cities in U.S. determines that in larger cities influenza incidence is more diffused. Urbanization has become the principal location for influenza transmission in human being due to overcrowded, slum areas, lack of infrastructure for adequate water & sanitation, and poor ventilation. Overcrowded and contact with infected persons has given rise in Influenza virus. Overcrowding, housing problems, traffic congestion, development of slum areas, poor nutrition diet, poor health, water and sanitation problems, are negative effects of urbanization which has led to increase in infectious disease. Air pollution is the major serious impact of urbanization due to industries and vehicles causes respiratory infections, heart diseases, and cancer. Urbanization has given rise in pandemic. Influenza virus has become the most common pathogen which causes respiratory diseases in autumn and winter season. Rise in prevalence of influenza virus has given rise in influenza diagnostic market growth. For instance in 2022, increase in urban population and immigrants started in 2019, activity of influenza like illness (ILI) has showed a sharp increase in 2019 at sub-center. It was determined that urbanization has shaping the intensity of influenza epidemics due to increase in population, population mobility, human contact, migration, etc. Urbanization has increased the possibility of incubation and transmission of virus from one person to another by human contact and population mobility. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in prevalence of influenza virus and population in urban areas boosts the demand for Influenza Diagnostic market.
Change in rapid weather variability
Change in rapid weather variability has become the major factor in target market growth. Changes in climatic conditions has given rise in influenza epidemic. Continuous change in earth’s climatic conditions has affect the viral activity and transmission of influenza. Influenza tend to enter nose and mouth. In winter season the cold weather slows down potential to clear the mucus in our nose which makes easier for viruses to enter and infect our body. Changes in rapid weather variability increase the risk of infection like transmission of influenza. It was determined clearly that temperature and absolute humidity has given positive impact on growth of influenza virus. Influenza occurs more commonly in seasonal epidemics during winter, temperate climatic conditions. In tropical regions influenza occurs throughout the year. However, change in rapid weather variability has given rise in influenza virus which has enhanced the growth of influenza diagnostic market.
Restrains:
However, currently based RIDTs used in physician office labs perform poorly and led to result in misdiagnose of influenza and serious consequences like inappropriate use of antibiotics and stringent FDA regulations which may somewhat restrain the influenza diagnostic market growth.
Influenza Diagnostics Market Segmentation
Influenza Diagnostic Market is segmented based on type, end-users and region.
Type Insight
On the basis of Type Influenza Diagnostic Market is segmented into RT-PCR, Viral Culture, Antigen Detection Tests, Serological Assays, Simple Amplification-based Assays, Molecular Assays, and others. RT-PCR (reverse transcriptase polymerase chain reaction), has dominated the target market as RT-PCR has become the gold standard in influenza diagnose as it is highly specific and sensitive to virus. RT-PCR is widely used due to its high accuracy and precision level.
End-Users Insights
On the basis of End-Users Influenza Diagnostic Market is segmented into Hospitals, Clinics, Diagnostic Laboratories and others. Diagnostic laboratories has dominated the target market due to availability of advancement and newly technique in diagnosing various diseases.
Regional Insights:
On region the Influenza Diagnostic Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising prevalence of influenza, advanced diagnostic centers, and strong focus of U.S. CDC (Centers for Disease Control and Prevention) in controlling rates of diseases is anticipated to increase demand for Influenza Diagnostic in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Type - RT-PCR, Viral Culture, Antigen Detection Tests, Serological Assays, Simple Amplification-based Assays, Molecular Assays, and others By End-Users - Hospitals, Clinics, Diagnostic Laboratories and others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Influenza Diagnostics Market report based on type, end-users and region:
Influenza Diagnostics Market, By Type:
- RT-PCR
- Viral Culture
- Antigen Detection Tests
- Serological Assays
- Simple Amplification-based Assays
- Molecular Assays
- Others
Influenza Diagnostics Market, By End-Users:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
Influenza Diagnostics Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Influenza Diagnostics Market Key Players
The key players operating the Influenza Diagnostic Market includes,
- Genes2Me
Genes2Me is India’s leading manufacturer of IVD kits and point of care solutions. Genes2Me offer products in areas like biochemistry, microbiology, haematology and immunology by providing RNA extraction kits, multiplexed genotyping assays, NGS kits, RT-PCR kits and rapid test kits.
- 3M Company
3M Company, is an American multinational conglomerate operating in various fields like U.S. healthcare, industry, consumer goods, and worker safety. 3M Company offer products like medical products, healthcare software and optical films, dental & orthodontic products, laminates, adhesives, electronic materials and others.
- Thermo Fisher Scientific Inc.
Thermo Fisher Scientific is an American supplier of regents and consumables, scientific instrumentation, and software services. Thermo Fisher Scientific provides clinical trial logistics, commercial manufacturing and industry leading pharmaceutical services & solutions for drug development.
- Abbott Laboratories
Abbott Laboratories, is an American multinational medical devices & healthcare company headquartered in Abbott Park, Illinois, U.S. Abbott offers wide range of diagnostic tools, science based nutritional products, vascular devices, branded generic pharmaceuticals and others.
- F. Hoffman-LA Roche AG
F. Hoffman-LA Roche AG is Swiss multinational healthcare company which provides medicines in infectious diseases, oncology, ophthalmology, immunology, and central nervous system disease. F. Hoffman-LA Roche AG is the world leader in tissue based cancer diagnostics and in-vitro diagnostics.
- Becton Dickinson and Company
Becton Dickinson and Company, is an American multinational medical technology company. Becton Dickinson and Company is the manufacturer and seller of reagents, instrument systems, and medical devices.
- Quidel Corporation
Quidel Corporation is headquartered in San Diego, California, U.S. Quidel is a leading manufacturer of diagnostic solutions. Quidel offer products which includes, media and controls, traditional cell lines, molecular assays, immunoassays, and others.
- Virax BioLabs
Virax BioLabs is global biotechnology company with three distinct platforms like virax immune – immunology and immunity passport software platform, virax care – innovative MedTech and distribution platform, and virax clear – diagnostic medical device distributor. Virax BioLabs offers in-vitro diagnostic kits.
- Luminex Corporation
Luminex Corporation is the developer, manufacturer and marketer of biological testing technologies in life science industries and clinical diagnostic. Luminex offers wide range of solutions in genomic & proteomic research, biomedical research, food safety, pharmaceutical drug discovery and clinical diagnostics.
- Hologic, Inc.
Hologic is headquartered in Marlborough, Massachusetts. Hologic is the medical technology company which is focused on women’s health. Hologic is the developer, manufacturer, and supplier of medical devices for surgery, diagnostics, and medical imaging.
Recent Development:
- In May 2022, Genes2Me has launched new ‘CovFlu’ which is first ‘Made in India’ RT-PCR kit used in detection and classification of COVID-19 and Influenza A & Influenza B virus within 50 minutes. Newly launched kit detects accurately Influenza A & B virus and SARS-CoV-2 virus. ‘CovFlu’ has received approval from DCGI and determined 100% specificity and sensitivity as per report of ICMR approved validation center. The newly launched kit is cost effective and supplied to government and private laboratories.
- In November 2022, Virax Biolabs has launched new RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit in Europe. Newly launched kit can be used at home and point of care settings for accurate identification of infections related to Influenza, RSV (respiratory syncytial virus, and COVID-19 virus with availability of result within 15 minutes.
Influenza Diagnostics Market Company Profile
- Genes2Me*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- 3M Company
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- F. Hoffman-LA Roche AG
- Becton Dickinson and Company
- Quidel Corporation
- Virax BioLabs*
- Luminex Corporation
- Hologic
“*” marked represents similar segmentation in other categories in the respective section
Influenza Diagnostics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By End-Users
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Influenza Diagnostics Market, By Type
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- RT-PCR
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Viral Culture
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Antigen Detection Tests
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Serological Assays
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Simple Amplification-based Assays
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Molecular Assays
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Influenza Diagnostics Market, By End-Users, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Diagnostic Laboratories
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Influenza Diagnostics Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Genes2Me
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- 3M Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F. Hoffman-LA Roche AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Becton Dickinson and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Quidel Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Virax BioLabs
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Luminex Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hologic
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Influenza Diagnostics Market is segmented into type, end-users and region.
Influenza Diagnostics Market is driven by factors like rise in prevalence of Influenza virus, rate of urbanization, and change in rapid weather variability.
By region, the Influenza Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.
The key players operating the Influenza Diagnostics Market includes, Genes2Me, 3M Company, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffman-LA Roche AG, Becton Dickinson and Company, Quidel Corporation, Virax BioLabs, Luminex Corporation, Hologic, and others.